Literature DB >> 18770580

Influenza: propagation, quantification, and storage.

Kristy J Szretter1, Amanda L Balish, Jacqueline M Katz.   

Abstract

Influenza viruses are negative-sense, single-stranded, enveloped RNA viruses belonging to the family Orthomyxoviridae. Three types exist, influenza A, B, and C. All infect humans, but only A and B are major human pathogens. Influenza type A viruses are divided into subtypes based on genetic and antigenic differences in the two surface spike proteins, hemagglutinin (HA) and neuraminidase (NA). The appropriate cell lines to be used for isolation of influenza A or B viruses depend on the clinical information and the host of origin. MDCK cells are the preferred cell line for isolation of human influenza viruses from clinical specimens.

Entities:  

Mesh:

Year:  2006        PMID: 18770580     DOI: 10.1002/0471729256.mc15g01s3

Source DB:  PubMed          Journal:  Curr Protoc Microbiol


  114 in total

1.  Coronavirus and influenza virus proteolytic priming takes place in tetraspanin-enriched membrane microdomains.

Authors:  James T Earnest; Michael P Hantak; Jung-Eun Park; Tom Gallagher
Journal:  J Virol       Date:  2015-04-01       Impact factor: 5.103

2.  Comparison of complement dependent lytic, hemagglutination inhibition and microneutralization antibody responses in influenza vaccinated individuals.

Authors:  Mary Dawn T Co; John Cruz; Akira Takeda; Francis A Ennis; Masanori Terajima
Journal:  Hum Vaccin Immunother       Date:  2012-08-16       Impact factor: 3.452

3.  Morphology and morphogenesis of SARS-CoV-2 in Vero-E6 cells.

Authors:  Debora Ferreira Barreto-Vieira; Marcos Alexandre Nunes da Silva; Cristiana Couto Garcia; Milene Dias Miranda; Aline da Rocha Matos; Braulia Costa Caetano; Paola Cristina Resende; Fernando Couto Motta; Marilda Mendonça Siqueira; Wendell Girard-Dias; Bráulio Soares Archanjo; Ortrud Monika Barth
Journal:  Mem Inst Oswaldo Cruz       Date:  2021-02-08       Impact factor: 2.743

4.  Attenuation of Influenza A Virus Disease Severity by Viral Coinfection in a Mouse Model.

Authors:  Andres J Gonzalez; Emmanuel C Ijezie; Onesmo B Balemba; Tanya A Miura
Journal:  J Virol       Date:  2018-11-12       Impact factor: 5.103

5.  Delta inulin polysaccharide adjuvant enhances the ability of split-virion H5N1 vaccine to protect against lethal challenge in ferrets.

Authors:  R Colby Layton; Nikolai Petrovsky; Andrew P Gigliotti; Zemmie Pollock; Jennifer Knight; Nathaniel Donart; John Pyles; Kevin S Harrod; Peng Gao; Frederick Koster
Journal:  Vaccine       Date:  2011-07-06       Impact factor: 3.641

6.  Quantification of heterosubtypic immunity between avian influenza subtypes H3N8 and H4N6 in multiple avian host species.

Authors:  K M Pepin; K K VanDalen; N L Mooers; J W Ellis; H J Sullivan; J J Root; C T Webb; A B Franklin; S A Shriner
Journal:  J Gen Virol       Date:  2012-09-05       Impact factor: 3.891

7.  A candidate H1N1 pandemic influenza vaccine elicits protective immunity in mice.

Authors:  Julia Steitz; Peter G Barlow; Jaber Hossain; Eun Kim; Kaori Okada; Tom Kenniston; Sheri Rea; Ruben O Donis; Andrea Gambotto
Journal:  PLoS One       Date:  2010-05-05       Impact factor: 3.240

8.  Systematic identification of H274Y compensatory mutations in influenza A virus neuraminidase by high-throughput screening.

Authors:  Nicholas C Wu; Arthur P Young; Sugandha Dandekar; Hemani Wijersuriya; Laith Q Al-Mawsawi; Ting-Ting Wu; Ren Sun
Journal:  J Virol       Date:  2012-11-14       Impact factor: 5.103

9.  Verdinexor, a novel selective inhibitor of nuclear export, reduces influenza a virus replication in vitro and in vivo.

Authors:  Olivia Perwitasari; Scott Johnson; Xiuzhen Yan; Elizabeth Howerth; Sharon Shacham; Yosef Landesman; Erkan Baloglu; Dilara McCauley; Sharon Tamir; S Mark Tompkins; Ralph A Tripp
Journal:  J Virol       Date:  2014-06-25       Impact factor: 5.103

10.  Inferring stabilizing mutations from protein phylogenies: application to influenza hemagglutinin.

Authors:  Jesse D Bloom; Matthew J Glassman
Journal:  PLoS Comput Biol       Date:  2009-04-17       Impact factor: 4.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.